A Clinical Trial to Evaluate the Efficacy of ConcenTrace to Buffer pH Levels Within the Body.

Trace Minerals40 enrolled

Overview

This virtual single-arm trial will last 12 weeks. Participants will take the drops daily and complete questionnaires at Baseline, Week 4, Week 8, and Week 12. Urine pH measurements will be taken at Baseline, Week 4, Week 8, and Week 12 using pH test strips.

Study Type

INTERVENTIONAL

Allocation

Purpose

OTHER

Masking

NONE

Enrollment

Conditions

Interventions

ConcenTraceOTHER

The product contains concentrated seawater from Utah's inland sea.

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Male or female. Aged 18+. Generally healthy - don't live with any uncontrolled disease. Willing to maintain their standard dietary pattern, activity level, and body weight for the duration of the study. Exclusion Criteria: * Anyone with a pre-existing chronic condition that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders. Anyone with known severe allergic reactions. Women who are pregnant, breastfeeding, or attempting to become pregnant. Anyone unwilling to follow the study protocol.

Locations (1)

Citruslabs

Santa Monica, California, United States

Outcomes

Primary Outcomes

Changes in urine pH levels. [Timeframe: Baseline to Week 12]

Participants will use pH test strips to measure urine pH. Changes in urine pH will be evaluated.

Time frame: 12 weeks

Secondary Outcomes

Change in score on the Metabolic Screening Questionnaire.

A Metabolic Screening Questionnaire (MSQ) was developed by the Toronto Centre for Naturopathic Medicine. The symptoms represented on a MSQ represent symptoms commonly associated with inflammation and toxicity. Participants will rate frequency and intensity of applicable symptoms according to the following scores: * Absent or rare symptoms - 0 points * Occasional, mild symptoms - 1 point * Occasional, severe symptoms - 2 points * Frequent, mild symptoms - 3 points * Frequent, severe symptoms - 4 points

Time frame: 12 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.